86 research outputs found
高機能自閉症スペクトラム障害成人の小集団認知行動療法による感情制御プログラムの効果検証 : ランダム化比較試験を用いて
学位の種別: 課程博士審査委員会委員 : (主査)東京大学教授 笠井 清登, 東京大学准教授 後藤 順, 東京大学講師 清水 潤, 東京大学教授 川上 憲人, 東京大学教授 岡 明University of Tokyo(東京大学
Convergence Stability of Depth-Depth-Matching-Based Steepest Descent Method in Simulated Liver Surgery
We recently established that our digital potential function was globally stable at the point where a virtual liver coincided with its real counterpart. In particular, because three rotational degrees of freedom are frequently used in a surgical operation on a real liver, stability of the potential function concerning three rotational degrees of freedom was carefully verified in the laboratory, using fluorescent lamps and sunlight. We achieved the same stability for several simulated liver operations using a 3D printed viscoelastic liver in a surgical operating room equipped with two light-emitting diode shadowless lamps. As a result, with increasing number of lamps, stability of our depth-depth matching in the steepest descendent algorithm improved because the lamps did not emit an infrared spectrum such as the one emitted by our depth camera. Furthermore, the slower the angular velocity in a surgical sequence, the more overall stability improved
Altered functional organization within the insular cortex in adult males with high-functioning autism spectrum disorder: evidence from connectivity-based parcellation
Determination of the optimal number of clusters based on VI and MI in intracalcarine cortex. The intracalcarine cortex was selected as a control region. The VI and MI values are shown for every clustering solution for k values ranging from 2 to 10. Arrows indicate either local minima of VI or local maxima of MI. Dashed lines denote the optimal number of solutions as determined using both VI and MI. The error bars denote standard errors of the mean for 100 repetitions of the split-half procedure (see the “Estimation of the optimal number of clusters” section). “n.s.” indicates no statistically significant difference between points. (PDF 334 kb
A novel mouse model of muscle wasting
Background
Formation of 43S and 48S preinitiation complexes plays an important role in muscle protein synthesis. There is no muscle-wasting mouse model caused by a repressed 43S preinitiation complex assembly.
Objective
The aim of the present study was to develop a convenient mouse model of skeletal muscle wasting with repressed 43S preinitiation complex assembly.
Material and methods
A ligand-activatable PERK derivative Fv2E-PERK causes the phosphorylation of eukaryotic initiation factor 2α (eIF2α), which inhibits 43S preinitiation complex assembly. Thus, muscle atrophic phenotypes, intracellular signaling pathways, and intracellular free amino acid profiles were investigated in human skeletal muscle α-actin (HSA) promoter-driven Fv2E-PERK transgenic (Tg) mice.
Results
HSA-Fv2E-PERK Tg mice treated with the artificial dimerizer AP20187 phosphorylates eIF2α in skeletal muscles and leads to severe muscle atrophy within a few days of ligand injection. Muscle atrophy was accompanied by a counter regulatory activation of mTORC1 signaling. Moreover, intracellular free amino acid levels were distinctively altered in the skeletal muscles of HSA-Fv2E-PERK Tg mice.
Conclusions
As a novel model of muscle wasting, HSA-Fv2E-PERK Tg mice provide a convenient tool for studying the pathogenesis of muscle loss and for assessing putative therapeutics
A cognitive-behavioral intervention for emotion regulation in adults with high-functioning autism spectrum disorders: study protocol for a randomized controlled trial
Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
<p>Abstract</p> <p>Background</p> <p>Antibody-dependent cellular cytotoxicity (ADCC) has recently been identified as one of the critical mechanisms underlying the clinical efficacy of therapeutic antibodies, especially anticancer antibodies. Therapeutic antibodies fully lacking the core fucose of the Fc oligosaccharides have been found to exhibit much higher ADCC in humans than their fucosylated counterparts. However, data which show how fully non-fucosylated antibodies achieve such a high ADCC in human whole blood have not yet been disclosed. The precise mechanisms responsible for the high ADCC mediated by fully non-fucosylated therapeutic antibodies, even in the presence of human plasma, should be explained based on direct evidence of non-fucosylated antibody action in human blood.</p> <p>Methods</p> <p>Using a human <it>ex vivo </it>B-cell depletion assay with non-fucosylated and fucosylated anti-CD20 IgG1s rituximab, we monitored the binding of the therapeutic agents both to antigens on target cells (target side interaction) and to leukocyte receptors (FcγR) on effector cells (effector side interaction), comparing the intensities of ADCC in human blood.</p> <p>Results</p> <p>In the target side interaction, down-modulation of CD20 on B cells mediated by anti-CD20 was not observed. Simple competition for binding to the antigens on target B cells between fucosylated and non-fucosylated anti-CD20s was detected in human blood to cause inhibition of the enhanced ADCC of non-fucosylated anti-CD20 by fucosylated anti-CD20. In the effector side interaction, non-fucosylated anti-CD20 showed sufficiently high FcγRIIIa binding activity to overcome competition from plasma IgG for binding to FcγRIIIa on natural killer (NK) cells, whereas the binding of fucosylated anti-CD20 to FcγRIIIa was almost abolished in the presence of human plasma and failed to recruit NK cells effectively. The core fucosylation levels of individual serum IgG1 from healthy donors was found to be so slightly different that it did not affect the inhibitory effect on the ADCC of fucosylated anti-CD20.</p> <p>Conclusion</p> <p>Our results demonstrate that removal of fucosylated antibody ingredients from antibody therapeutics elicits high ADCC in human blood by two mechanisms: namely, by evading the inhibitory effects both of plasma IgG on FcγRIIIa binding (effector side interaction) and of fucosylated antibodies on antigen binding (target side interaction).</p
CO Multi-line Imaging of Nearby Galaxies (COMING) IV. Overview of the Project
Observations of the molecular gas in galaxies are vital to understanding the
evolution and star-forming histories of galaxies. However, galaxies with
molecular gas maps of their whole discs having sufficient resolution to
distinguish galactic structures are severely lacking. Millimeter wavelength
studies at a high angular resolution across multiple lines and transitions are
particularly needed, severely limiting our ability to infer the universal
properties of molecular gas in galaxies. Hence, we conducted a legacy project
with the 45 m telescope of the Nobeyama Radio Observatory, called the CO
Multi-line Imaging of Nearby Galaxies (COMING), which simultaneously observed
147 galaxies with high far-infrared flux in CO, CO, and CO
lines. The total molecular gas mass was derived using the standard
CO-to-H conversion factor and found to be positively correlated with the
total stellar mass derived from the WISE m band data. The fraction of
the total molecular gas mass to the total stellar mass in galaxies does not
depend on their Hubble types nor the existence of a galactic bar, although when
galaxies in individual morphological types are investigated separately, the
fraction seems to decrease with the total stellar mass in early-type galaxies
and vice versa in late-type galaxies. No differences in the distribution of the
total molecular gas mass, stellar mass, and the total molecular gas to stellar
mass ratio was observed between barred and non-barred galaxies, which is likely
the result of our sample selection criteria, in that we prioritized observing
FIR bright (and thus molecular gas-rich) galaxies.Comment: Accepted for publication in PASJ; 47 pages, 5 tables, 29 figures.
On-line supplementary images are available at this URL
(https://astro3.sci.hokudai.ac.jp/~radio/coming/publications/). CO data is
available at the Japanese Virtual Observatory (JVO) website
(https://jvo.nao.ac.jp/portal/nobeyama/coming.do) and the project website
(https://astro3.sci.hokudai.ac.jp/~radio/coming/data/
- …